Test Price
2,800 AEDโ Home Collection Available
TCAP Gene Limb-Girdle Muscular Dystrophy Type 2G (LGMDR2) Genetic Test in UAE | 2800 AED | DHA Licensed
Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics:
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance:
Telephonic Post-Test Clinical Guidance for result interpretation led by a DHA-licensed Consultant Medical Geneticist.
Insurance:
Direct Billing Verification via WhatsApp +971 54 548 8731. Instant pre-approval check.
Executive Summary & Core Metrics
The TCAP gene NGS test accurately diagnoses autosomal recessive limb-girdle muscular dystrophy type 2G (LGMDR2) by sequencing the entire coding region of the TCAP gene. This definitive genetic analysis empowers neurologists and clinical geneticists to confirm disease, guide prognosis, and inform reproductive risk. The test is offered exclusively by DNA Labs UAE under DHA Facility License 1143, ensuring full regulatory compliance and clinical reliability.
Test Overview & Methodology
This assay utilizes next-generation sequencing (NGS) to achieve comprehensive coverage of the TCAP gene coding region and splice sites. The methodology detects single nucleotide variants, small insertions and deletions with greater than 99.9% sensitivity, providing a definitive molecular diagnosis for LGMDR2. Results are correlated with clinical presentation to guide management and family counselling.
| Feature | Our Test (NGS Full Gene) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity for SNVs and small indels | 85-90% for point mutations; misses copy-number variants |
| Methodology | Next-Generation Sequencing (NGS) with complete gene coverage | Targeted Sanger sequencing, exon by exon |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks (often longer if multiple exons) |
Physician Insight & Safety Protocols
โAs a Consultant Medical Geneticist with extensive experience in hereditary neuromuscular disorders, I emphasize that a positive TCAP result confirms the molecular aetiology but must be interpreted alongside the complete clinical and electrophysiological picture. Continue all prescribed therapies and attend regular follow-up. Any new or worsening cardiac or respiratory symptoms warrant immediate evaluation.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory on Medication Continuity
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace clinical management decisions.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Not suitable for patients who have received a blood transfusion within 2 weeks (may interfere with DNA analysis). Minors require documented parental consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: Acute severe muscle weakness affecting breathing; new-onset chest pain, palpitations or syncope; sudden loss of ability to walk; signs of rhabdomyolysis (dark urine, severe muscle pain).
- If any of these occur, go to the nearest emergency department immediately.
This test is a DNA-only analysis; it does not replace clinical evaluation. Always consult your managing physician for interpretation.
Patient FAQ & Clinical Guidance
1. What is the purpose of the TCAP gene test?
This test detects pathogenic variants in the TCAP gene to confirm a clinical diagnosis of limb-girdle muscular dystrophy type 2G with greater than 99% sensitivity. It also identifies carrier status, aiding family planning and cascade screening among relatives.
2. How is the sample collected and what is the turnaround time?
A standard peripheral whole blood sample is collected via our VIP Mobile Phlebotomy service operating daily from 8 AM to 11 PM. Samples are transported using ISO-certified temperature-controlled cold chain logistics. Results are delivered within 3 to 4 weeks. Pre-test genetic counselling is mandatory and included in the service.
3. Does insurance cover this test in the UAE?
Most UAE insurers partially or fully cover genetic testing for suspected hereditary neuromuscular disorders when clinically indicated. We verify your coverage directly via WhatsApp before the blood draw. Contact +971 54 548 8731 for an instant pre-approval check.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Patient Safety
This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | TCAP Gene Limb-Girdle Muscular Dystrophy Type 2G (LGMDR2) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Dried Blood Spot, or DNA Sample |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full Gene Coverage |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 81247-5 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians